FDA, drug development, regulation, industry

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

Pharma edition

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.